LIFE SCIENCES Strategic Business Unit VELOXTAR™

Fast disintegrating,Simple manufacturing VELOXTAR™

What is VELOXTAR™ technology?

What is VELOXTAR™ technology? What is VELOXTAR™ technology?

VELOXTAR™ is a technology that produces a very thin orally disintegrating tablet (ODT) like a coin. The distinctive tablet shape and unique formulation design allow the ODTs to disintegrate in 4-6 seconds.
There are several technologies to prepare ultra-rapid ODTs (UR-ODT). One of that is lyophilization. The advantage of lyophilized ODTs is extremely short disintegration time in 1-3 seconds, however, the tablets are fragile and easily moistened after opening the packages. Additionally, special equipment is required for the production.
Another method of producing ODTs is dry tableting. Although it is a simple process that can manufacture ODTs with higher hardness and practical hygroscopic stability, they are difficult to disintegrate not more than 10 seconds like lyophilized ODTs.
VELOXTAR™ is a state-of-the-art technology that combines the advantages of lyophilization and dry tableting method. VELOXTAR™ technology significantly reduces the disintegration time, while still providing practical tablet hardness.

Features of VELOXTAR™ ODTs

  • 01

    Ultra rapid disintegration in 4-6 seconds in the oral cavity

    The disintegration is realized with the distinctive shape and our unique formulation technology.

  • 02

    Simple manufacturing process

    VELOXTAR™ ODTs can be manufactured by the dry tableting method.

  • 03

    Sufficient hygroscopic stability

    VELOXTAR™ ODTs are less prone to significant performance loss due to moisture absorption. They are ease to handle after opening than lyophilized ODTs.

  • 04

    Practical tablet strength

    Despite of the thinness, VELOXTAR ODT™ has practical strength without cracking and chipping.

VELOXTAR™ ODTs are suitable for these patients with:

  • Medication refusal (e.g., Schizophrenia, Alzheimer 's disease)
  • Seizure (e.g., Migraine, Angina attack)
  • Restriction of fluid intake (e.g., Kidney disease, Nocturia)
  • Dysphagia (e.g., Parkinson's disease)
  • Poor swallowing ability (e.g., Pediatric and geriatric)
VELOXTAR™ ODTs are suitable for these patients with:

Related Information